CXCL10 and COVID-19: Severe COVID-19 patients showed impaired IFN-1 signaling compared to mild patients, and developed an inappropriate inflammatory state due to early delay in IFN-1 expression and activation of pro-inflammatory cytokines (IL-1, IL-6, IL-8, MCP-1, and CXCL-10) (26–28).